Director at Moderna (MRNA) receives 16,233 shares as RSUs vest

Rhea-AI Filing Summary

Moderna, Inc. director Elizabeth G. Nabel acquired common shares through an equity award vesting. On April 30, 2026, 16,233 restricted stock units converted into 16,233 shares of common stock on a one-for-one basis. These RSUs vested in full on that date.

After the conversion, Nabel directly owned 19,317 shares of Moderna common stock. The filing shows an exercise or conversion of a derivative security related to compensation, with no open-market purchase or sale reported in this transaction.

Insider Trade Summary

16,233 shares exercised/converted

Mixed 2 txns

Insider NABEL ELIZABETH G

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	16,233	$0.00	--
Exercise	Common Stock	16,233	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 19,317 shares (Direct, null)

Footnotes (1)

1. Restricted stock units convert into common stock on a one-for-one basis. The shares subject to this restricted stock unit award vested in full on April 30, 2026.

Key Figures

RSUs converted: 16,233 units Shares acquired: 16,233 shares Shares owned after: 19,317 shares +1 more

4 metrics

RSUs converted 16,233 units Restricted stock units converting into common stock on April 30, 2026

Shares acquired 16,233 shares Common stock received from RSU conversion on April 30, 2026

Shares owned after 19,317 shares Total Moderna common stock directly held after the transaction

Exercise price $0.00 per share RSUs converting into common stock with no cash exercise price

Key Terms

Restricted Stock Units, derivative security, one-for-one basis

3 terms

Restricted Stock Units financial

"The shares subject to this restricted stock unit award vested in full on April 30, 2026."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

one-for-one basis financial

"Restricted stock units convert into common stock on a one-for-one basis."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NABEL ELIZABETH G

(Last) (First) (Middle)

C/O MODERNA, INC.

325 BINNEY STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Moderna, Inc. [ MRNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		M(1)		16,233	A	(1)	19,317	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	04/30/2026		M(1)			16,233	(2)	(2)	Common Stock	16,233	$0	0	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. The shares subject to this restricted stock unit award vested in full on April 30, 2026.

	/s/ James Dillon, as Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Moderna (MRNA) director Elizabeth Nabel report in this Form 4?

Elizabeth Nabel reported the vesting and conversion of equity awards. On April 30, 2026, 16,233 restricted stock units converted into 16,233 shares of Moderna common stock, increasing her directly held stake to 19,317 shares after the transaction.

How many Moderna (MRNA) shares did Elizabeth Nabel acquire in this transaction?

Elizabeth Nabel acquired 16,233 shares of Moderna common stock. These shares came from restricted stock units that converted into common stock on a one-for-one basis when they vested in full on April 30, 2026, rather than from an open-market purchase.

Were any Moderna (MRNA) shares sold in Elizabeth Nabel’s latest Form 4?

No sales were reported in this Form 4. The filing shows an exercise or conversion of 16,233 restricted stock units into the same number of common shares, with no open-market disposition or tax-withholding sale disclosed as part of this specific transaction.

What does the vesting of restricted stock units mean for Moderna (MRNA) director ownership?

Vesting means the director’s equity award became fully earned and converted into shares. For Elizabeth Nabel, 16,233 restricted stock units vested in full on April 30, 2026 and became common stock, bringing her directly owned Moderna share count to 19,317 afterward.

How are Elizabeth Nabel’s restricted stock units in Moderna (MRNA) structured?

The restricted stock units convert into common stock on a one-for-one basis. In this filing, 16,233 RSUs vested in full on April 30, 2026 and were exchanged for 16,233 Moderna common shares, reflecting a standard equity compensation structure for directors.